Accendra Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -29.0% | -147.4% | – | -76.5% | +160.0% | -149.4% | – | -558.7% | – | -173.4% | – | – | |
| – | -4.0% | +4.7% | -13.8% | -3.5% | +5.8% | -6.2% | -77.2% | +360.5% | -53.4% | +106.7% | +6.4% | – | |
| – | +1.0% | +18.4% | -1.9% | -15.7% | +33.0% | -8.3% | -29.8% | -51.8% | -290.4% | – | +29.6% | – | |
| – | -71.9% | -426.4% | – | -119.0% | – | – | – | -261.3% | – | -126.6% | – | – | |
| – | +11.3% | -12.3% | -7.3% | +34.3% | +2.1% | +2.9% | +33.1% | -32.8% | -83.9% | +675.4% | -33.9% | – | |
| – | +19.1% | -95.2% | +1,780.7% | -22.7% | +92.4% | -7.8% | +9.8% | -25.4% | – | -81.1% | -157.9% | – | |
| – | – | – | – | – | – | – | +242.8% | +29.2% | -47.1% | -100.0% | – | – | |
| – | – | – | – | – | -83.5% | – | -61.5% | +261.9% | -149.5% | – | -595.1% | – | |
| – | -72.0% | – | -246.7% | +155.1% | -78.4% | – | -65.8% | +471.3% | -164.9% | – | -632.4% | – | |
| – | – | -109.4% | – | -7,516.0% | – | – | -310.6% | – | – | -76.7% | -699.8% | – | |
| – | -48.1% | -284.7% | – | -148.6% | – | -1,321.3% | – | – | – | -62.8% | -435.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.